1. A Systematic Review on the Application of Virtual Reality for Muscular Dystrophy Rehabilitation: Motor Learning Benefits
- Author
-
Universidad de Sevilla. Departamento de Fisioterapia, Kiper, Pawel, Federico, Sara, Szczepańska-Gieracha, Joanna, Szary, Patryk, Wrzeciono, Adam, Mazurek, Justyna, Luque Moreno, Carlos, Kiper, Aleksandra, Spagna, Mattia, Barresi, Rita, Cieślik, Błażej, Universidad de Sevilla. Departamento de Fisioterapia, Kiper, Pawel, Federico, Sara, Szczepańska-Gieracha, Joanna, Szary, Patryk, Wrzeciono, Adam, Mazurek, Justyna, Luque Moreno, Carlos, Kiper, Aleksandra, Spagna, Mattia, Barresi, Rita, and Cieślik, Błażej
- Abstract
Using virtual reality (VR) for Muscular Dystrophy (MD) rehabilitation promises to be a novel therapeutic approach, potentially enhancing motor learning, functional outcomes, and overall quality of life. This systematic review primarily aimed to provide a comprehensive summary of the current understanding regarding the application of VR in supporting MD rehabilitation. A systematic search was performed in PubMed, Scopus, Cochrane Library, and Web of Science to identify relevant articles. The inclusion criteria encompassed studies involving individuals diagnosed with MD who underwent VR interventions, with a primary focus on assessing functional improvement. Methodological quality of the studies was assessed by using the Physiotherapy Evidence Database (PEDro) scale. Seven studies, involving 440 individuals with Duchenne Muscular Dystrophy (DMD), were included in the review. Among these studies, six primarily explored the motor learning potential of VR, while one study investigated the impact of VR training on functional abilities. In conclusion, the qualitative synthesis supports VR-based interventions’ potential positive effects on motor learning, performance improvement, and functional outcomes in individuals with DMD. However, current usage mainly focuses on assessing the potential mechanisms’ benefits, suggesting the importance of expanding clinical adoption to harness their therapeutic potential for MD patients.
- Published
- 2024